Seminars in Nuclear Medicine
Volume 37, Issue 3 , Pages 185-194 , May 2007

Structural and Functional Imaging of Normal Bone Marrow and Evaluation of Its Age-Related Changes

References 

  1. Knowles S, Hoffbrand AV. Bone-marrow aspiration and trephine biopsy (2). BMJ. 1980;281:204–205
  2. Vande Berg BC, Malghem J, Lecouvet FE, et al. Magnetic resonance imaging of the normal bone marrow. Skeletal Radiol. 1998;27:471–483
  3. Piney A. The anatomy of the bone marrow with special reference to the distribution of the red marrow. Br Med J. 1922;28:792–795
  4. Politis C, Karamerou A, Block M. Pathophysiologic aspects of the bone/marrow/fat relationship. Lab Management. 1983;21:40–55
  5. Hashimoto M. Pathology of bone marrow. Acta Haematol. 1962;27:193–216
  6. Kricun ME. Red-yellow marrow conversion: Its effect on the location of some solitary bone lesions. Skeletal Radiol. 1985;14:10–19
  7. Vande Berg BC, Lecouvet FE, Moysan P, et al. MR assessment of red marrow distribution and composition in the proximal femur: Correlation with clinical and laboratory parameters. Skeletal Radiol. 1997;26:589–596
  8. Cristy M. Active bone marrow distribution as a function of age in humans. Phys Med Biol. 1981;26:389–400
  9. Hartsock RJ, Smith EB, Petty CS. Normal variations with aging of the amount of hematopoietic tissue in bone marrow from the anterior iliac crest (A study made from 177 cases of sudden death examined by necropsy). Am J Clin Pathol. 1965;43:326–331
  10. Vogler JB, Murphy WA. Bone marrow imaging. Radiology. 1988;168:679–693
  11. Baglin TP, Crocker J, Timmins A, et al. Bone marrow hypervascularity in patients with myelofibrosis identified by infra-red thermography. Clin Lab Haematol. 1991;13:341–348
  12. Lang P, Fritz R, Majumdar S, et al. Hematopoietic bone marrow in the adult knee: Spin-echo and opposed-phase gradient-echo MR imaging. Skeletal Radiol. 1993;22:95–103
  13. Kaplan PA, Asleson RJ, Klassen LW, et al. Bone marrow patterns in aplastic anemia: Observations with 1.5-T MR imaging. Radiology. 1987;164:441–444
  14. Poulton TB, Murphy WD, Duerk JL, et al. Bone marrow reconversion in adults who are smokers: MR Imaging findings. AJR Am J Roentgenol. 1993;161:1217–1221
  15. Fullerton G. Physiologic Basis of Magnetic Relaxation. St. Louis, MO: Mosby; 1992;
  16. Wehrli FW, MacFall JR, Shutts D, et al. Mechanisms of contrast in NMR imaging. J Comput Assist Tomogr. 1984;8:369–380
  17. Mitchell DG, Burk DL, Vinitski S, et al. The biophysical basis of tissue contrast in extracranial MR imaging. AJR Am J Roentgenol. 1987;149:831–837
  18. Parizel PM, Van Riet B, van Hasselt BA, et al. Influence of magnetic field strength on T2* decay and phase effects in gradient echo MRI of vertebral bone marrow. J Comput Assist Tomogr. 1995;19:465–471
  19. Ricci C, Cova M, Kang YS, et al. Normal age-related patterns of cellular and fatty bone marrow distribution in the axial skeleton: MR imaging study. Radiology. 1990;177:83–88
  20. Duda SH, Laniado M, Schick F, et al. Normal bone marrow in the sacrum of young adults: differences between the sexes seen on chemical-shift MR imaging. AJR Am J Roentgenol. 1995;164:935–940
  21. Mitchell DG, Rao VM, Dalinka M, et al. Hematopoietic and fatty bone marrow distribution in the normal and ischemic hip: new observations with 1.5-T MR imaging. Radiology. 1986;161:199–202
  22. Ishijima H, Ishizaka H, Horikoshi H, et al. Water fraction of lumbar vertebral bone marrow estimated from chemical shift misregistration on MR imaging: Normal variations with age and sex. AJR Am J Roentgenol. 1996;167:355–358
  23. Kugel H, Jung C, Schulte O, et al. Age- and sex-specific differences in the 1 H-spectrum of vertebral bone marrow. J Magn Reson Imaging. 2001;13:263–268
  24. Dooms GC, Fisher MR, Hricak H, et al. Bone marrow imaging: Magnetic resonance studies related to age and sex. Radiology. 1985;155:429–432
  25. Dunnill MS, Anderson JA, Whitehead R. Quantitative histological studies on age changes in bone. J Pathol Bacteriol. 1967;94:275–291
  26. Saifuddin A, Bann K, Ridgway JP, et al. Bone marrow blood supply in gadolinium-enhanced magnetic resonance imaging. Skeletal Radiol. 1994;23:455–457
  27. Montazel JL, Divine M, Lepage E, et al. Normal Spinal bone marrow in adults: Dynamic gadolinium-enhanced MR imaging. Radiology. 2003;229:703–709
  28. Sze G, Bravo S, Baierl P, et al. Developing spinal column: gadolinium-enhanced MR imaging. Radiology. 1991;180:497–502
  29. Daldrup-Link HE, Franzius C, Link TM, et al. Whole-body MR imaging for detection of bone metastases in children and young adults: Comparison with skeletal scintigraphy and FDG PET. AJR Am J Roentgenol. 2001;177:229–236
  30. Datz FL, Taylor A. The clinical use of radionuclide bone marrow imaging. Semin Nucl Med. 1985;15:239–259
  31. Kim CK, Reske SN, Alavi A. In: Bone marrow scintigraphy, in Nuclear Medicine. St. Louis: Mosby; 1996;p. 1223–1249
  32. Engstedt L, Franzen S, Jonsson L, et al. In vivo localization of colloidal Au198 intravenously injected in polycythemia vera; A preliminary report. Acta Radiol. 1958;49:66–71
  33. Desai AG, Thakur ML. Radiopharmaceuticals for spleen and bone marrow studies. Semin Nucl Med. 1985;15:229–238
  34. Noworolska A, Harlozinska A, Richter R, et al. Non-specific cross-reacting antigen (NCA) in individual maturation stages of myelocytic cell series. Br J Cancer. 1985;51:371–377
  35. Wahren B, Gahrton G, Hammarstrom S. Nonspecific cross-reacting antigen in normal and leukemic myeloid cells and serum of leukemic patients. Cancer Res. 1980;40:2039–2044
  36. Wahren B, Gahrton G, Ruden U, et al. Clinical evaluation of NCA in patients with chronic myelocytic leukemia. Int J Cancer. 1982;29:133–137
  37. Munz DL, Sandrock D, Rilinger N. Comparison of immunoscintigraphy and colloid scintigraphy of bone marrow. Lancet. 1990;336:258–259
  38. Reske SN, Buell U. Reduced technetium 99m labelled NCA-95/CEA-antibody uptake in liver due to gentle antibody reconstitution (Technical note). Eur J Nucl Med. 1990;17:38–41
  39. Reske SN, Karstens JH, Gloeckner W, et al. Radioimmunoimaging for diagnosis of bone marrow involvement in breast cancer and malignant lymphoma. Lancet. 1989;1:299–301
  40. Hotze A, Low A, Mahlstedt J, et al. [Combined bone marrow and skeletal scintigraphy in osseous and myelogenous diseases]. Rofo. 1984;140:717–723
  41. Blend MJ, Pavel DG. Bone marrow imaging: A comparison study using a 99Tcm-sulphur colloid versus a new 99Tcm-microaggregated albumin. Nucl Med Commun. 1986;7:787–789
  42. Van Dyke D, Price D, Shkurkin C, et al. Differences in distribution of erythropoietic and reticuloendothelial marrow in hematologic disease. Blood. 1967;30:364–374
  43. Beamish MR, Brown EB. The metabolism of transferrin-bound 111In and 59Fe in the rat. Blood. 1974;43:693–701
  44. Greenberg ML, Atkins HL, Schiffer LM. Erythropoietic and reticuloendothelial function in bone marrow in dogs. Science. 1966;152:526–528
  45. Nelp WB, Bower RE. The quantitative distribution of the erythron and the RE cell in the bone marrow organ of man. Blood. 1969;34:276–282
  46. Fordham E, Amjal A. Radionuclide imaging of bone marrow. Semin Hematol. 1981;18:222–239
  47. Meyer MA, Nathan CA. Reduced F-18 fluorodeoxyglucose uptake within marrow after external beam radiation. Clin Nucl Med. 2000;25:279–280
  48. Alavi A, Lakhani P, Mavi A, et al. PET: a revolution in medical imaging. Radiol Clin North Am. 2004;42:983–1001
  49. Cheran SK, Herndon JE, Patz EF. Comparison of whole-body FDG-PET to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer. Lung Cancer. 2004;44:317–325
  50. Durski JM, Srinivas S, Segall G. Comparison of FDG-PET and bone scans for detecting skeletal metastases in patients with non-small cell lung cancer. Clin Positron Imaging. 2000;3:97–105
  51. El-Haddad G, Zhuang H, Gupta N, et al. Evolving role of positron emission tomography in the management of patients with inflammatory and other benign disorders. Semin Nucl Med. 2004;34:313–329
  52. Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: Physiologic and benign variants. Radiographics. 1999;19:61–77quiz 150-151
  53. Abdel-Dayem HM, Sanchez J, al-Mohannadi S, et al. Diffuse thallium-201-chloride uptake in hypermetabolic bone marrow following treatment with granulocyte stimulating factor. J Nucl Med. 1992;33:2014–2016
  54. Sugawara Y, Zasadny KR, Kison PV, et al. Splenic fluorodeoxyglucose uptake increased by granulocyte colony-stimulating factor therapy: PET imaging results. J Nucl Med. 1999;40:1456–1462
  55. Abdel-Dayem HM, Rosen G, El-Zeftawy H, et al. Fluorine-18 fluorodeoxyglucose splenic uptake from extramedullary hematopoiesis after granulocyte colony-stimulating factor stimulation. Clin Nucl Med. 1999;24:319–322
  56. Hollinger EF, Alibazoglu H, Ali A, et al. Hematopoietic cytokine-mediated FDG uptake simulates the appearance of diffuse metastatic disease on whole-body PET imaging. Clin Nucl Med. 1998;23:93–98
  57. Mayer D, Bednarczyk EM. Interaction of colony-stimulating factors and fluorodeoxyglucose f(18) positron emission tomography. Ann Pharmacother. 2002;36:1796–1799
  58. Udupa JK, Odhner D, Samarasekera S, et al. 3DVIEWNIX: an open, transportable multidimensional, multimodality, multiparametric imaging software system. Proc SPIE. 2003;2164:58

PII: S0001-2998(07)00018-9

doi: 10.1053/j.semnuclmed.2007.01.002

Seminars in Nuclear Medicine
Volume 37, Issue 3 , Pages 185-194 , May 2007

Article Tools

* Image Usage & Resolution